BRUKER FluoroCycler® XT is a new PCR instrument for highly multiplexed PCR assays and the only instrument to support the innovative LiquidArray® technology. Moreover, it is compatible with all commercial and in-house PCR assays. Thereby, FluoroCycler® XT offers you the utmost flexibility and versatility.
FluoroCycler® XT – Excellent PCR instrument for innovative highly multiplexed PCR assays
- High-performance PCR instrument for all known PCR technologies
- The only instrument supporting the unique LiquidArray® technology
- Compatibility with all commercial or in-house PCR assay
- FluoroSoftware® XT-IVD offers an objective analysis of FluoroType® assays
- AssayArea for analysis of other commercial assays
- Result interpretation summarized in the FluoroCycler® XT Report
Detecting SARS-CoV-2 with FluoroCycler® XT
FluoroType® SARS-CoV-2 plus is a multiplex real-time PCR test, which detects SARS-CoV-2, the novel β-coronavirus causing COVID-19. The test targets two independent genes of the SARS-CoV-2 genome, while simultaneously allowing for the differentiation of non-SARS-CoV-2 patients by detecting four endemic human coronaviruses (HCoVs). The assay is validated on respiratory samples (nasopharyngeal/oropharyngeal swabs) and produces results in less than two hours from extraction.
Coronavirus disease 2019 (COVID-19)
In 2019, SARS-CoV-2 emerged as a novel pathogen causing coronavirus disease 2019 (COVID-19). Categorized as a pandemic by the World Health Organisation (WHO) in March 2020, COVID-19 affected multiple countries across all populated continents. Rapid testing plays an important role as societies seek to contain, delay, and mitigate the effects of the outbreak.
Many labs are in need of a rapid and specific detection method to assist with outbreak management. The WHO recommends that suspected cases are screened by nucleic acid amplification tests.
Results at a glance in combination with the FluoroCycler® XT
Using the Bruker FluoroCycler® XT high-performance thermocycler, results are provided in an automatically generated report using integrated software and results interpretation. The results can be read and reported at a glance’.
The FluoroType® SARS-CoV-2 plus kit works with an encapsulated RNA Internal Control, which mimics lysis of viral particles and serves as an extraction, reverse transcription, and amplification control. The kit is validated with the GenoXtract® combined with dedicated extraction kits, to provide high-quality nucleic acids with confidence.